A new genome-wide association study suggests that a liver condition called primary sclerosing cholangitis (PSC) is likely a distinct disease from inflammatory bowel disease (IBD), despite the genetic and clinical overlap between the conditions. Roughly three-quarters of individuals with PSC also develop IBD, with around four-fifth of those IBD cases involving ulcerative colitis diagnoses.